Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

11294	Companies
250977	Keywords
179892	Articles
136847	Press releases

Home
Companies
Biophytis

REGULATED PRESS RELEASE

published on 07/07/2025 at 07:00, 1 year 4 months ago

Obesity: Biophytis Charts Its Course Toward a Booming Market
Biophy.s SA is focusing on developing transformative therapies for obesity, sarcopenia, and longevity by addressing muscle loss with its lead drug BIO101. The company's strategic positioning targets the expanding obesity market

BIO101 Obesity Market Opportunity Muscle Loss Biophy.s SA
BRIEF

published on 07/03/2025 at 07:05, 1 year 4 months ago

Biophytis Showcases Innovations at BIO International 2025

Biophytis Precision Medicine Longevity Sarcopenia Obesity Therapy
BRIEF

published on 07/03/2025 at 07:05, 1 year 4 months ago

Biophytis : Avancées Thérapeutiques Présentées à la BIO International 2025

Biophytis Innovations Santé Thérapies Convention BIO 2025
REGULATED PRESS RELEASE

published on 07/03/2025 at 07:00, 1 year 4 months ago

Biophytis Propulse l’Innovation dans l’Obésité, la Santé Musculaire et la Longévité à la BIO International 2025
BiophyHs SA présente ses avancées dans l'obésité, la sarcopénie et la longévité à la BIO Interna(onal 2025, soulignant ses thérapies innovantes et partenariats stratégiques pour le développement mondial

Longévité Sarcopénie Obésité BiophyHs SA BIO InternaHonal 2025
REGULATED PRESS RELEASE

published on 07/03/2025 at 07:00, 1 year 4 months ago

Biophythis Powers Innovation in Obesity, Muscle Health, and Longevity at BIO International 2025
Biophytis highlights innovations in obesity, muscle health, and longevity at BIO International 2025, showcasing therapies targeting key health challenges. Strategic partnerships post-conference aim to accelerate therapies' global impact

Innovations Longevity Obesity Muscle Health Biophy(s
PRESS RELEASE

published on 07/03/2025 at 06:59, 1 year 4 months ago

Biophytis Propulse l’Innovation dans l’Obésité, la Santé Musculaire et la Longévité à la BIO International 2025
BiophyHs annonce son succès à la BIO International Convention 2025, présentant des avancées en obésité, sarcopénie et longévité, avec des partenariats stratégiques post-conférence

Longévité Sarcopénie Obésité BIO International Convention 2025 BiophyHs
BRIEF

published on 06/30/2025 at 22:35, 1 year 4 months ago

Biophytis Delays Publication of 2024 Annual Financial Statements

Biophytis Biotechnology Drug Development Annual Accounts Financial Delay
BRIEF

published on 06/30/2025 at 22:35, 1 year 4 months ago

Biophytis reporte la publication de ses comptes annuels

Biophytis Biotechnologie Comptes Annuels Recherche Clinique Publication Retardée
REGULATED PRESS RELEASE

published on 06/30/2025 at 22:30, 1 year 4 months ago

Information sur les comptes annuels
Biophytis SA informe qu'elle n'est pas en mesure de publier ses comptes annuels 2024 à la date prévue mais les publiera au plus tard le 07 juillet 2025

Biophytis Développement Biotechnologie Comptes Annuels Maladies Liées À L'âge
REGULATED PRESS RELEASE

published on 06/30/2025 at 22:30, 1 year 4 months ago

Information on the Annual Financial Statements
Biophytis delays publishing of 2024 annual accounts, aiming for release by July 7. The company focuses on treatments for age-related diseases

Financial Statements Biophytis Age-related Diseases 2024 Annual Accounts Clinical-stage Biotechnology Company

Accesswire

Published on 11/06/2026 at 22:15, 2 days 9 hours ago

Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 18 hours ago

Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 18 hours ago

Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 18 hours ago

Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 10:00, 2 days 21 hours ago

Mongolia Tax Audit

View all ACCESSWIRE

EQS Group

Published on 11/09/2026 at 07:10, 11 minutes ago

Hypoport delivers solid gross profit growth and an increase in EBIT in the first nine months of 2026
Published on 11/09/2026 at 07:00, 21 minutes ago

Sandoz launches new semaglutide treatment option in Brazil, expanding patient access to GLP-1 medicine in key global market
Published on 11/09/2026 at 07:00, 21 minutes ago

Cicor receives awards for two major defence programmes
Published on 11/09/2026 at 01:55, 5 hours 26 minutes ago

EQS-Adhoc: NEXTDC Limited: Response to Statement by Goodman Group & Digital Realty
Published on 11/08/2026 at 12:10, 19 hours 10 minutes ago

GSMA MWC26 Doha opens with call to align on global industry standards and close MENA's connectivity gap

Les Echos

Published on 11/09/2026 at 07:00, 21 minutes ago

bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 21 minutes ago

BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 21 minutes ago

Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine
Published on 11/09/2026 at 07:00, 21 minutes ago

bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour les dernières versions des tests BIOFIRE® FILMARRAY® Gastrointestinal Panels afin d’optimiser la détection des pathogènes gastrointestinaux, dont le norovirus
Published on 11/06/2026 at 19:06, 2 days 12 hours ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026

View all LES ECHOS COMFI WIRE